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There is scanty information on the effect of L-arginine supplementation on glucose metabolism 
in HbSS patients. The effect of six weeks L-arginine supplementation (1g/day) on oral glucose 
tolerance test (OGTT) and insulin resistance (HOMA-IR was investigated in 40 adult HbSS and 
40 adult HbAA subjects. After a 12-hour overnight fast, 3 mL of blood was withdrawn from an 
ante-cubital vein of each subject for the estimation of fasting blood glucose (FBG), insulin, L-
arginine concentration [R], catalase (CAT), superoxide dismutase (SOD), glutathione 
peroxidase (GPx) and MDA. OGTT was performed on each subject and then placed on L-
arginine for 6 weeks. Parameters were re-measured at the end of the period. Before 
supplementation, FBG, fasting insulin, HOMA-IR, MDA were higher in HbSS subjects. CAT, 
SOD, GPX were higher in HbAA subjects. In response to OGTT, glucose and insulin peaked at 
30 minutes in HbAA subjects and at 60 minutes in HbSS subjects. Supplementation did not 
affect these patterns of responses to OGTT. In HbSS subjects, L-arginine reduced FBG, insulin, 
HOMA-IR and MDA but increased insulin and HOMA-IR in HbAA subjects. ∆[R] correlated 
negatively with ∆glucose, ∆insulin and ∆HOMA-IR respectively in HbSS subjects but positively 
in HbAA subjects. In HbSS subjects, ∆HOMA-IR correlated negatively with ∆CAT, ∆SOD and 
∆GPx respectively but positively in HbAA subjects. Study thus showed impaired glucose and 
insulin responses to OGTT in HbSS subjects that were not affected by arginine. Supplementation 
ameliorated insulin resistance and oxidative stress burden in these subjects.  
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INTRODUCTION   
Sickle cell haemoglobinopathy is common among black 
populations of the world especially Africa and arises 
from a replacement on the beta chain of haemoglobin of 
gluthamic acid by valine at the 6th position (Ingram, 
1956). Sickle cell anaemia (SCA) is characterized by 
abnormal haemoglobin production, chronic haemolytic 
anaemia and periodic, painful vaso-occlusive events 
which result in acute or chronic tissue damage, organ 
dysfunction as well as organ damage (Raghupathy and 
Billett, 2009). Abnormal erythrocyte membrane and 
subsequent chronic hemolysis had been reported as the 




Hebbel, 2000). It had been suggested that chronic 
inflammation in SCA sufferers led to damage of the β-
cell of the pancreas, causing decreased insulin 
production and defective glycaemic control (Fung et al., 
2006). Al-Sultan et al. (2010) showed that the average 
levels of fasting blood glucose, insulin and homeostasis 
model assessment of insulin resistance (HOMA-IR) 
were significantly elevated in sickle cell disease (SCD) 
patients as compared to the controls. In addition, 
oxidative products (expressed as malondialdehyde and 
carbonyl levels) were significantly correlated with blood 
glucose, insulin level, and HOMA-IR in SCD. However, 
Akinlade et al. (2014) observed similar insulin level but 
lower level of fasting glucose in SCA subjects compared 
to HbAA subjects. They also showed that patients with 
SCA had similar insulin sensitivity status as HbAA 
individuals. Furthermore, Yavroupaulou et al. (2017) 
showed that normoglycemic patients with SCD 
demonstrated impaired β-cell function with reduced 
insulin secretion even before OGTT was impaired.  
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Other studies demonstrated an association between 
SCA, inflammation, altered basal metabolic rate and 
impaired glucose metabolism (Okafor and Osamo, 1982; 
Borel et al., 1998). Inspite of these findings, diabetes 
mellitus is a rare finding among SCD sufferers (Reid et 
al., 1998, Akinlade et al., 2018). 
L-Arginine, an amino acid, is an anti-oxidant and its 
supplementation had shown some promise as a 
therapeutic agent in the management of SCD. Its 
usefulness in the treatment of SCD had been supported 
by several human studies. In sickle cell anaemia 
subjects, arginine increased antioxidant enzymes levels 
(Little et al., 2009; Kehinde et al., 2015), nitric oxide 
availability [Morris et al., 2000], and enhanced blood 
trace metals levels (Ogungbemi et al., 2018). 
Futhermore, attenuated pressor and heart rate responses 
to change in posture (Ogungbemi et al., 2013) and 
reduced elevated liver enzymes (ALT, AST and ALP) 
levels (Jaja et al., 2016) were observed in HbSS subjects 
supplemented with arginine. In addition, arginine caused 
a significant reduction in total opioid use and pain scores 
in children that had acute pain crises (Morris et al., 
2013].  
Amino acids such as L-arginine are insulin 
secretagogues (Gannon and Nuttall, 2010). By this 
property, L-arginine could elevate insulin levels in SCD 
sufferers precipitating unwanted or unanticipated 
complications in this group of subjects that have a rare 
occurrence of diabetes mellitus (Reid et al., 1998; 
Akinlade et al., 2018). Inspite of its many potential 
benefits to SCA patients, the effect of L-arginine on 
glucose tolerance and insulin resistance in these subjects 
has not been reported. 
This study investigated the effect of L-arginine 
supplementation on glucose and insulin responses to 
OGTT in SCA using non SCA with HbAA as controls. 
It also examined the effect of arginine supplementation 
on the relationship between insulin resistance and 




Forty non SCA subjects (20 males and 20 females) and 
forty SCA subjects (20 males and 20 female) were 
studied after due ethical approval had been obtained 
from the Lagos University Teaching Hospital (LUTH) 
Health Research Ethics Committee 
(ADM/DCST/HREC/APP/1359). The HbAA subjects 
(electrophoretically determined) were students of 
tertiary institutions in Lagos, Nigeria. The HbSS 
subjects were patients in the steady state 
(electrophoretically determined) attending the Out-
Patients’ Sickle Cell Clinic of LUTH, Lagos, Nigeria. 
Drug history, family history of diabetes mellitus and/or 
hypertension, and frequency of blood transfusion were 
obtained using a short-structured questionnaire. 
Excluded from the study were subjects with other forms 
of genotype apart from HbSS (this was confirmed 
through haemoglobin electrophoresis), diabetes 
mellitus, hypertension, human immunodeficiency virus 
(HIV), hepatitis, cancer and established endocrine 
dysfunctions. 
All subjects gave informed consent before 
participating in the study. On entering the laboratory 
after a 12-hour overnight fast, the age (years) height 
(centimeter) and weight (kilogram) of each subject were 
measured and recorded. Three milliliter of blood was 
withdrawn from an ante-cubital vein of each subject: 1 
mL was put into EDTA bottle for the estimation of blood 
cell indices including red blood cell (RBC) count, 
packed cell volume (PCV), haemoglobin concentration 
(Hb), mean corpuscular haemoglobin (MCH), mean 
corpuscular haemoglobin concentration (MCHC) and 
mean corpuscular volume (MCV)) and 2 mL into plain 
sample bottle for the estimation of  fasting blood 
glucose, plasma insulin, L-arginine (R) and  antioxidant 
enzymes activities (CAT, SOD and GPx) and 
malondialdehyde (MDA). Serum was obtained by 
centrifuging blood at 3000 rpm for 15 minutes. Each 
subject was then placed on L-arginine supplement at a 
dose of 1 g/day for six weeks (Kehinde et al., 2015). L-
arginine powder, 100% pure-free form, (NOW FOODS, 
Dallas, USA) was capsulated at the Herbal Clinic, 
Department of Pharmacognosy, University of Lagos, 
Lagos, Nigeria. After the six weeks of L-arginine 
supplementation, the aforementioned procedure and 
measurements were taken again.  
  
Estimation of some haematological parameters  
Red blood cell count (RBC, million/mm3), packed cell 
volume (PCV, %) haemoglobin concentration [Hb, 
g/dL], mean corpuscular volume (MCV, fL), mean 
corpuscular haemoglobin (MCH, pg) and mean 
corpuscular haemoglobin concentration (MCHC, g/dL), 
were determined using an automated counter (Mindray 
BC 2800 Haematology Automated System, China). 
 
Determination of plasma L-arginine concentration (R, 
μmol/L). 
L-Arginine concentration was determined using an assay 
kit, (Oxford Biomedical Research, U. S. A.).  
 
Assay of insulin. 
Insulin was assayed using commercial assay kit and 
following manufacturer’s (DiaMetra, Italy) instructions.  
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Determination of blood glucose 
Fasting blood glucose was determined by using the 
ONETOUCH Ultra 2 Blood glucose monitoring system 
(LIFESCAN, CHINA).  
 
Estimation of malondialdehyde 
Malondialdehyde, (MDA), level in blood was 
determined using the thiobarbituric acid method. 
Malondialdehyde was estimated using the 
spectrophotometer at 535 nm based on the principle that 
lipidperoxides condense with 1-methyl-2-phenyl indole 
under acidic conditions (Titus et al., 2004). 
 
Determination of serum levels of antioxidant enzymes.  
Serum CAT and SOD levels were assayed as described 
by Rukkumani et al, (2004) while serum GPx level was 
measured as described by Ellman (1959). 
 
Data Analyses 
The homeostasis model assessment of insulin resistance 
(HOMA-IR) was calculated as:  
HOMA-IR = [fasting insulin (U/mL) × fasting glucose 
(mmol/L)]/22.5 (Matthews et al., 1985).  
Results are presented as mean ± SEM. Statistical 
analyses were made using Graph pad prism 5. Statistical 
comparisons were made using paired Student’s t-test and 




Table 1 shows a comparison of the physical 
characteristics of the subjects. Before arginine 
supplementation, plasma arginine (R) in both groups of 
subjects was similar (Table 2; a Vs b). The table also 
shows that plasma NOX, CAT and GPX were higher in 




Table1.  Comparison of Physical and some haematological 
parameters of subjects.    






Age (years) 30.7 ± 1.0 27.5 ±1.2    NS 
Height (cm) 172.5 ± 2.0 167.5 ± 2.0    NS 
Weight (kg) 69.2 ± 1.0 59.8 ± 1.1 < 0.01 
BMI 23.1 ± 0.6 21.8 ± 0.6 < 0.05 
Hct (%) 40.3 ± 1.3   26.1 ± 1.1 < 0.001 
RBC (106/µL)                                      4.8 ± 0.2                           3.2 ± 0.2 < 0.001 
Hb (g/dL) 13.7 ± 0.4 8.9 ± 0.3 < 0.001 
 




Conversely, SOD, MDA, fasting glucose, fasting insulin 
and HOMA-IR were significantly higher in HbSS 
subjects than in the HbAA subjects. (Table 2; a Vs b).  
In HbAA subjects, arginine supplementation had little or 
no effect on fasting glucose concentration, decreased 
MDA (p<0.01) and significantly elevated the other 
measured parameters (Table 2; a Vs c). In HbSS 
subjects, supplementation decreased MDA (p<0.001), 
fasting glucose (p <0.05), fasting insulin and HOMA-IR 
(p<0.001 in each case). All other measured parameters 
were significantly elevated (See Table 2; b Vs d). 
Fig. 1 shows glucose and insulin responses to OGTT 
before supplementation with L-Arginine in both groups 
of subjects. In HbAA subjects, blood glucose peaked at 
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30 minutes and thereafter declined while in HbSS 
subjects, blood glucose peaked at 60 minutes and 
thereafter declined. Insulin responses to OGTT in both 
groups of subjects followed the same pattern as glucose 
responses in HbAA and HbSS groups respectively. 
 
Table 3: Correlation coefficient (r) between measured 
variables. 
 
*=p< 0.05; **=p<0.01; ***=p<0.001 
 
 
Fig.1: Glucose and insulin responses to glucose loading before 
L-arginine supplementation in HbAA and HbSS subjects. 
 
 
Fig. 2: Glucose and insulin responses to glucose loading 
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Fig. 2 shows glucose and insulin responses to OGTT 
after   L-arginine   supplementation   in both   groups of 
subjects. Supplementation did not change the pattern of 
glucose response in either of the two groups. Thus, 
glucose response peaked at 30 minutes in HbAA 
subjects and at 60 minutes in HbSS subjects. The pattern 
of insulin response in either of the groups was also 
unaffected by supplementation. 
  
Table 3 shows correlation coefficients (r) calculated 
between change in serum arginine concentration ([∆R]) 
or change in insulin resistance (∆HOMA-IR) and the 
other measured parameters in the subjects. In HbAA 
subjects, [∆R] correlated positively with ∆glucose (0.66; 
p<0.05), ∆insulin 0.79; p<0.01), ∆HOMA-IR (0.80; 
p<0.001). In HbSS subjects, [R] correlated negatively 
with ∆glucose (-0.82; p<0.001), ∆insulin (-0.88; 
p<0.001), and ∆HOMA-IR (-0.88; p<0.001) (Table 3). 
Table 3 also shows that in HbAA subjects ∆HOMA-IR 
correlated positively with each of the antioxidant 
enzymes but correlated negatively with each of the 
antioxidant enzymes in the HbSS subjects.  
 
DISCUSSION 
This study has shown that in HbSS subjects fasting 
plasma glucose, fasting serum insulin and HOMA-IR 
levels were elevated above normal values in contrast to 
HbAA subjects whose values were within the normal 
ranges. These results agree with those of Al-Sultan et al. 
(2010) but contrast those of Akinlade et al. (2014). Thus, 
HbSS subjects exhibit insulin resistance. In addition, 
after OGTT, glucose and insulin levels in HbAA 
subjects peaked at 30 minutes and progressively fell at 
60, 90 and 120 minutes showing a normal response to 
OGTT (Takahashi et al., 2018) while in HbSS subjects, 
glucose and insulin peaked at 60 minutes and thereafter 
fell, suggesting an impaired response to OGTT 
(Takahashi et al., 2018). 
Our results also show that there was a higher level of 
oxidative stress burden in the HbSS subjects as 
evidenced by lower blood Arginine, CAT, SOD, and 
GPX and higher MDA in comparison to the HbAA 
subjects. This agrees with earlier studies (Kehinde et al., 
2015).That L-arginine supplementation increased blood 
arginine, CAT, SOD and GPX while MDA fell in both 
groups of subjects agrees with earlier findings (Little et 
al., 2009; Morris et al., 2000; Ogungbemi et al., 2018). 
In HbAA subjects, arginine supplementation did not 
affect fasting glucose but elevated fasting blood insulin 
and HOMA-IR. In addition, arginine did not affect the 
pattern of glucose or insulin response to OGTT in these 
subjects. Pahlavani et al, (2017) had however shown that 
arginine supplementation reduced fasting blood glucose 
in healthy men. The elevation of blood insulin by 
arginine supplementation in HbAA subjects may be due 
to the fact that arginine is an insulin secretagogue. It 
must be noted, however, that although insulin and 
HOMA-IR values were elevated by arginine 
supplementation, the values remained within normal 
limits.  
In HbSS subjects, supplementation decreased fasting 
blood glucose, fasting insulin, HOMA-IR and did not 
affect the pattern of glucose or insulin response to 
OGTT. Although these effects may be due to the disease, 
it is however not clear by what mechanisms L-arginine 
achieved these effects. The significantly negative 
correlation coefficients between change (∆) in blood 
arginine level and change in blood glucose or insulin or 
HOMA-IR or MDA confirm an inverse relationship 
between blood arginine levels and those measured 
parameters. The significantly positive correlations 
between change (∆) in blood arginine and change (∆) in 
CAT or SOD or GPx levels confirm that arginine 
supplementation caused the elevation of the blood 
antioxidant enzymes levels and agrees with earlier 
observations ((Little et al., 2009; Kehinde et al., 2015). 
Reduction in malondialdehyde level with a concomitant 
increase in antioxidant enzymes levels signifies a 
reduction in oxidative stress burden in these subjects 
(Kehinde et al., 2015). Furthermore, the significantly 
negative correlation coefficients calculated between 
change in HOMA-IR and change in each of the 
antioxidant levels suggest that elevated antioxidant 
enzymes levels possibly brought about by arginine 
supplementation contributed to the lowering of insulin 
resistance in the sickle cell disease subjects. In summary, 
low dose, oral, chronic arginine supplementation may 
have exerted its effect on insulin resistance through the 
reduction of oxidative stress burden. Earlier studies had 
shown that oxidative stress may interfere with insulin 
signaling by impairing insulin uptake through a direct 
effect on insulin receptor functions (Houstis et al., 2006; 
Dokken et al., 2008) which in turn leads to an increase 
in plasma insulin level. On the other hand, oxidative 
stress may reduce glucose uptake by inhibiting the 
translocation of glucose transporter to the plasma 
membrane leading to increased blood glucose 
concentration (Garvey et al., 1998) which in turn 
induces pancreatic secretion of insulin. 
Earlier studies had suggested the arginine-nitric 
oxide pathway as the major pathway for arginine activity 
in sickle cell anaemia (Morris et al., 2000; Bakshi and 
Morris, 2016). Some other studies had suggested that 
arginine may exert its beneficial effects by reducing 
oxidative stress burden in sickle cell disease sufferers. 
Co-administering hydroxyurea with L-Arginine 
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increased the plasma level of glutathione peroxidase in 
HbSS patients (Little et al., 2009). In addition, arginine 
supplementation decreased oxidative stress burden by 
increasing total antioxidant enzymes and decreasing 
malondialdehyde (MDA) levels in HbSS subjects 
(Kehinde et al., 2015). Ogungbemi et al, (2018) also 
demonstrated that arginine supplementation elevated 
trace metals levels and antioxidant enzymes levels in 
HbSS subjects. Trace metals form an integral part of 
antioxidant enzymes and may contribute to the integrity 
and proper functioning of the antioxidant enzymes. 
Dosage of L-arginine. 
 
In this study, 100% pure-free form L-arginine powder, 
(NOW FOODS, Dallas, USA) capsulated at the Herbal 
Clinic, Department of Pharmacognosy, University of 
Lagos, Lagos, Nigeria was used. Each subject was 
placed on L-arginine supplement at a dose of 1 g/day for 
six weeks. Although low-dose L-arginine had been 
found to be sub-therapeutic, repeated supplementation 
with lower doses may restore depleted arginine stores 
and become therapeutic (Morris et al., 2000). The 
authors could not find any study that investigated the 
effect of L-arginine supplementation on glucose 
metabolism in SCD sufferers even though arginine 
supplementation may be beneficial in the management 
of diabetes mellitus (Stancic et al., 2012).  
L-arginine had been reported to exert some side 
effects when supplemented in high, supraphysiological 
doses and for long periods of time. Higher oral doses of 
L-arginine-HCl (>9 g/day) had been associated with 
nausea, gastrointestinal discomfort, and diarrhea 
(Grimble, 2007; Stancic et al., 2012). Apart from 
inducing changes in numerous chemicals and 
electrolytes in the blood, including potassium it could 
also cause anaphylaxis (Stancic et al., 2012).  
There are some limitations to this study. We did not 
explore the effect of higher doses of L-Arginine. 
Lifestyle was also not controlled. Subjects were allowed 
their normal diets and their daily routines. Investigators 
depended on the subjects to regularly take their daily 
supplements and only confirmed through telephone 
calls. This study was not planned as a clinical trial. 
Therefore, these results will have to be authenticated by 
a well-structured, randomized, blinded, placebo-
controlled study to give it more validity. 
 
In conclusion, this study has shown that in SCA subjects, 
chronic, low dose, oral supplementation with l-arginine 
did not affect the impaired glucose and insulin responses 
to OGTT. However, supplementation reduced blood 
glucose, blood insulin and insulin resistance in these 
subjects by probably reducing oxidative stress.  
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